Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell death in protists without mitochondria.
Chose O, Sarde CO, Noël C, Gerbod D, Jimenez JC, Brenner C, Capron M, Viscogliosi E, Roseto A. Chose O, et al. Ann N Y Acad Sci. 2003 Dec;1010:121-5. doi: 10.1196/annals.1299.021. Ann N Y Acad Sci. 2003. PMID: 15033707 Review.
Distributed automated manufacturing of pluripotent stem cell products.
Shariatzadeh M, Chandra A, Wilson SL, McCall MJ, Morizur L, Lesueur L, Chose O, Gepp MM, Schulz A, Neubauer JC, Zimmermann H, Abranches E, Man J, O'Shea O, Stacey G, Hewitt Z, Williams DJ. Shariatzadeh M, et al. Among authors: chose o. Int J Adv Manuf Technol. 2020;106(3):1085-1103. doi: 10.1007/s00170-019-04516-1. Epub 2019 Dec 4. Int J Adv Manuf Technol. 2020. PMID: 31983799 Free PMC article.
The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles.
Jarrige M, Frank E, Herardot E, Martineau S, Darle A, Benabides M, Domingues S, Chose O, Habeler W, Lorant J, Baldeschi C, Martinat C, Monville C, Morizur L, Ben M'Barek K. Jarrige M, et al. Among authors: chose o. Cells. 2021 Jan 27;10(2):240. doi: 10.3390/cells10020240. Cells. 2021. PMID: 33513719 Free PMC article. Review.
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.
Chabot S, Jabrane-Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, Noman MZ, Giustiniani J, Bellard E, Brayer S, Aguerre-Girr M, Meggetto F, Giuriato S, Malecaze F, Galiacy S, Jaïs JP, Chose O, Kadouche J, Chouaib S, Teissié J, Abitbol M, Bensussan A, Le Bouteiller P. Chabot S, et al. Among authors: chose o. J Exp Med. 2011 May 9;208(5):973-86. doi: 10.1084/jem.20100810. Epub 2011 Apr 11. J Exp Med. 2011. PMID: 21482699 Free PMC article.